Baldoni John has filed 4 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 9846 shares of MiNK Therapeutics, Inc. ($INKT) on September 01, 2023.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 1, 2023 | MiNK Therapeutics, Inc. | $INKT | Baldoni John | Not found | A | Common stock | 9846 | $1.46 | 41,193.0000 | 0 | 31.41% | 0.00% |
| June 14, 2023 | MiNK Therapeutics, Inc. | $INKT | Baldoni John | Director | A | Stock Option (Right to Buy) | 22500 | $0.00 | 22,500.0000 | 0 | 9999.99% | 0.00% |
| June 1, 2023 | MiNK Therapeutics, Inc. | $INKT | Baldoni John | Director | A | Common stock | 8168 | $1.76 | 31,528.0000 | 0 | 34.97% | 0.00% |
| March 1, 2023 | MiNK Therapeutics, Inc. | $INKT | Baldoni John | Director | A | Common stock | 6878 | $2.09 | 23,360.0000 | 0 | 41.73% | 0.00% |